- Home
- / CTI BioPharma
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
CTI BioPharma financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$9.1
2023-06-23
Market Capitalization
$1.2 B
2023-06-23
Revenue
$53.9 M
FY, 2022
CreditSafe Score
?
Score changed on Jun 08, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2011 | FY, 2012 | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 | FY, 2017 | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 34.7M | 60.1M | 16.1M | 57.4M | 25.1M | 26.3M | 3.3M | 53.9M | ||||
| Revenue growth, % | 73.2% | -73.2% | 256.2% | |||||||||
| Cost of goods sold | 137.0K | 895.0K | 1.9M | 1.4M | 364.0K | 879.0K | 3.5M | |||||
| Gross profit | 34.5M | 59.2M | 14.2M | 56.0M | 24.8M | 25.4M | 50.4M | |||||
| Gross profit margin, % | 99.6% | 98.5% | 88.0% | 97.6% | 98.6% | 96.7% | 93.5% | |||||
| General and administrative expense | 38.3M | 38.2M | 42.3M | 56.2M | 54.0M | 45.3M | 31.4M | 21.2M | 19.2M | 17.6M | 56.2M | 84.8M |
| Operating expense total | 73.2M | 71.4M | 76.1M | 145.4M | 130.8M | 105.2M | 64.3M | 58.3M | 43.3M | 47.8M | 130.2M | |
| EBIT | (62.2M) | (101.5M) | (41.5M) | (86.2M) | (116.7M) | (49.2M) | (39.5M) | (32.9M) | (40.7M) | (47.8M) | (95.3M) | (79.8M) |
| EBIT margin, % | -119.7% | -143.5% | -723.9% | -85.6% | -157.2% | -125.1% | -1217.1% | -147.9% | ||||
| Investment income | 1.2M | 1.2M | 204.0K | |||||||||
| Interest expense | 1.0M | 56.0K | 2.0M | 8.0M | 4.1M | 3.8M | 1.3M | 3.5M | ||||
| Pre tax profit | (86.7M) | (110.9M) | (51.9M) | (40.2M) | (29.2M) | (40.2M) | (52.5M) | (97.9M) | (93.0M) | |||
| Net Income | (62.4M) | (101.4M) | (42.7M) | (93.4M) | (119.4M) | (52.0M) | (40.7M) | (29.3M) | (40.0M) | (52.5M) | (97.9M) | (93.0M) |
| EPS | (0.8) |